Heartflow (HTFL) Amortization of Deferred Charges (2024 - 2025)

Heartflow (HTFL) posted quarterly Amortization of Deferred Charges of -$2.2 million for Q4 2025, down 426.89% year-over-year from $683417.0 in Q4 2024, and down 239.45% quarter-over-quarter from $1.6 million in Q3 2025.

Heartflow (HTFL) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Heartflow's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$2.2 million for Q4 2025.

  • In Q4 2025, Amortization of Deferred Charges fell 426.89% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at -$372000.0 (changed N/A YoY), while the FY2025 annual figure was $3.1 million, up 94.72% from the prior year.
  • Amortization of Deferred Charges for Q4 2025 stood at -$2.2 million, down from $1.6 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.6 million in Q3 2025, with the low at -$2.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Privia Health 2.78 Bn 2.42 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.23 Mn
Dec 31, 2025 -2.23 Mn
Sep 30, 2025 1.60 Mn
Sep 30, 2025 1.60 Mn
Dec 31, 2024 -424,000.00
Dec 31, 2024 -424,000.00
Sep 30, 2024 684,000.00
Sep 30, 2024 684,000.00